-

Global Medical REIT Inc. Announces Strategic Rebrand to Chiron Real Estate Inc.

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to “Chiron Real Estate Inc.” Beginning on February 23, 2026, the Company’s common stock will trade on the New York Stock Exchange (the “NYSE”) under the new name, “Chiron Real Estate Inc.,” and ticker symbol “XRN.”

“After spending the last six months evaluating and redefining our strategy, we are rebranding to better align with our new mission,” Mark Decker, Jr., Chief Executive Officer, said. “Chiron (Kai-ron), a figure from Greek mythology known for his knowledge and skill with medicine, was highly revered as a teacher and tutor and we believe Chiron embodies our refreshed mission: to deliver value at the intersection of care, capital and real estate, and our values of integrity and thought leadership.”

The Company expects to publish an investor presentation outlining the Company’s 2026 strategic objectives alongside its fourth quarter earnings release.

In connection with the name change, effective on February 23, 2026, the Company’s trading symbols on the NYSE will change from “GMRE” to “XRN” for the Company’s common stock, from “GMRE PrA” to “XRN PrA” for the Company’s Series A Preferred Stock, par value $0.001 per share, and from “GMRE PrB” to “XRN PrB” for the Company’s Series B Preferred Stock, par value $0.001 per share.

The Company’s rebrand will affect the Company’s business operations through its passion to deliver value for all its stakeholders, but it will not affect some of the Company’s core components such as its organizational structure, stockholder rights or qualification as a REIT for U.S. federal income tax purposes. The Company’s outstanding securities will remain valid, and no action is required by securityholders because of the name or ticker changes. There will be no change to the Company’s CUSIP numbers in connection with the name and ticker symbol changes.

The Company’s new corporate website, www.chironre.com will go live on February 23, 2026.

About Global Medical REIT Inc.

Global Medical REIT Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Additional information on GMRE can be obtained on its website at www.globalmedicalreit.com.

Forward-Looking Statements

Certain statements contained herein may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company’s intent that any such statements be protected by the safe harbor created thereby. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "plan," "predict," "project," "will," "continue" and other similar terms and phrases, including references to assumptions and forecasts of future results. Except for historical information, the statements set forth herein including, but not limited to, any statements regarding the timing of and the Company’s ability to consummate its rebrand to Chiron Real Estate Inc. and the effects of the name change on the Company’s operations, stockholder rights or REIT status. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although the Company believes that the expectations, estimates and assumptions reflected in its forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of the Company’s forward-looking statements. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and in our other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and undertakes no obligation, to update any forward-looking statement.

Contacts

Investor Relations:
Email: Investors@globalmedicalreit.com
Phone: 202.524.6869

Global Medical REIT Inc.

NYSE:GMRE

Release Versions

Contacts

Investor Relations:
Email: Investors@globalmedicalreit.com
Phone: 202.524.6869

More News From Global Medical REIT Inc.

Global Medical REIT Reports Tax Treatment of 2025 Dividends

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company’s website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Note: Data for common dividends paid in January, April and July 2025 have been adjusted to refle...

Global Medical REIT Inc. Announces Henry Cole Stepping Down from its Board of Directors

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Henry Cole has notified the Board of Directors (the “Board”) that he plans to step down as a member of the Board at the end of his current term. Henry Cole’s Stepping Down from Board of Directors Mr. Cole has served on the Board as an Independent Director since the Company’s inception and has served at different points throughout his term as the Board’s Lead Independent Director,...

Global Medical REIT Inc. Announces Retirement of Ronald Marston from its Board of Directors and Declares 2025 Fourth Quarter Common and Preferred Dividends

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company’s 2025 fourth quarter common and preferred dividends. Ronald Marston’s Retirement from Board of Directors Mr. Marston has served on the Board since 2015 as an independent director and at differ...
Back to Newsroom